Related Experiment Video
Updated: Oct 3, 2025
05:12
Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
Published on: September 4, 2017
11.1K
[Molecular Pathogenesis of Cerebral Cavernous Malformations].
Hiroki Hongo1, Yu Teranishi, Satoru Miyawaki
1Department of Neurosurgery, the University of Tokyo.
No Shinkei Geka. Neurological Surgery
|February 16, 2022
Summary
Cerebral cavernous malformations (CCMs) are vascular disorders causing seizures and strokes. Understanding CCM genetic mutations and pathways is advancing targeted molecular therapies beyond surgery.
Area of Science:
- Neurology
- Vascular Biology
- Genetics
Background:
- Cerebral cavernous malformations (CCMs) are vascular anomalies comprising dilated capillaries and veins.
- CCMs commonly lead to significant neurological issues, including epileptic seizures, hemorrhagic strokes, and focal deficits.
- Current treatment for CCMs is limited to surgical resection.
Purpose of the Study:
- To review the current understanding of the molecular pathogenesis of cerebral cavernous malformations.
- To highlight the role of genetic mutations and signaling pathways in CCM development.
- To discuss the implications for targeted molecular therapies.
Main Methods:
- Literature review of studies on CCM molecular pathogenesis.
- Analysis of genetic and signaling pathway research in CCMs.
- Synthesis of current knowledge on CCM mechanisms.
Main Results:
- Identification of germline and somatic mutations contributing to CCMs.
- Elucidation of key signaling pathways involved in CCM development.
- Progress in developing targeted molecular therapies for CCMs.
Conclusions:
- Advances in understanding CCM molecular pathogenesis are paving the way for novel therapeutic strategies.
- Targeted molecular therapies show promise as alternatives or adjuncts to surgical resection for CCMs.
- Further research into CCM mechanisms is crucial for improving patient outcomes.
